CSDT GMD
CSDT GMD
CSDT GMD
CSDT
Common Submission
Dossier Template
General Medical Device
Overview OF CSDT
• Reference Doc – MDA/GD/0008 – 1st Edition.
• Should be prepared by a manufacturer as a
summary of the technical documentation of
the medical device.
• Must contain all elements of CSDT as specified
in Appendix 2 of third Schedule of Medical
Device Regulation 2012.
• Should be in English or Bahasa Malaysia
• The information contained in the CSDT should
be supported by relevant supporting
documents for example copies of labels,
certificates and reports.
Element Of CSDT
Executive Summary 01
05 Device Labelling
Essential Principal
02
Conformity Checklist (EPSP)
06 Risk Analysis
Device Description 03
Summary of Design
Verification & Validation 04 07 Manufacturer Information
Documentations
1. Executive Summary
.
1.1. Device Overview
• Introduction to the device.
• Describe the device on how the device work.
Example:
5
1.3. Intended Use and Indication
• based on Label/Instruction for Use (IFU).
6
2. Essential Principle Conformity
Checklist (EPSP)
.
EPSP
➢ References Documents:
MDA/GD/0007: The Essential Principles of Safety and
Performance of Medical Devices
10
EPSP
General
Principle
Content Of
EPSP
Design and
Manufacturing
Principle
EPSP
➢General Principles – Mostly are related with manufacturing
process that comply with quality management system and risk
management process. Example :
❖Devices shall achieve the performance intended by the
manufacturer and be designed, manufactured and packaged in such
a way that they are suitable for one or more of the functions within
the scope of the definition of a medical device applicable in each
jurisdiction.
❖The devices shall be designed, manufactured and packed in such a
way that their characteristics and performances during their
intended use will not be adversely affected under transport and
storage conditions (for example, fluctuations of temperature and
humidity) taking account of the instructions and information provided
by the manufacturer.
❖The benefits must be determined to outweigh any undesirable side
effects for the performances intended.
EPSP
➢11 Design and Manufacturing Principles
1. Chemical, physical and biological properties
❖ Example: Implant system, Catheter, IVF fertilization medium
❖ ISO 10993-1: 2018 Biological evaluation of medical devices
❖ ISO 14607:2018 Non-active surgical implants -- Mammary implants
❖ ISO 13408-1:2008 Aseptic Processing of Health Care Products
9. Protection against the risks posed to the patient for devices or self-
testing or self-administration.
EPSP
➢11 Design and Manufacturing Principles
10. Information supplied by manufacturer.
❖ Example: Product Labelling/IFU
❖ ISO 15223-1:2016 Medical devices -- Symbols to be used with
medical device labels, labelling and information to be supplied
❖ ISO 14155 Clinical Investigation of Medical Devices for Human Subjects - Good clinical practice
❖ ISO 14644 Cleanrooms and Associated Controlled Environments
❖ ISO 17664 Processing of Health Care Products - Information to be Provided by the Medical Device
Manufacturer for the Processing of Medical Devices
❖ ISO 80369 Small-Bore Connectors for Liquids and Gases in Healthcare Applications
❖ ISO 22442 Medical Devices Utilizing Animal Tissues and their Derivatives
❖ IEC 60601 Medical Electrical Equipment
❖ IEC 61010 Safety Requirements for Electrical Equipment for Measurement, Control, and Laboratory
Use
❖ IEC 62366-1 Medical Devices - Part 1: Application of Usability Engineering to Medical Devices
❖ IEC 62366-2 Medical Devices - Part 2: Guidance on the Application of Usability Engineering to
Medical Devices
❖ IEC 80001 Application of Risk Management for IT Networks Incorporating Medical Devices
❖ IEC 62304 Medical device software - Software Life Cycle Processes
3. Device Description
.
3.1. Description of the Medical Device
13
3.4. Description of Accessories
14
3.6. Novel Features
• Specific for device that have new and different features with other
device.
• Clinical test is compulsory to validate the device performance and
safety.
15
3.8. Alternative Therapy
• Any other alternative or device that will have the same intended
purpose.
3.9. Materials
• List out all the materials of the device.
• Compulsory for device that can give effect to the patient body
16
4. Summary Of Design Verification &
Validation Documentation.
.
4.1. Pre-clinical Studies
A stage of research/test before clinical trials/test. Usually focus on the
safety of the product.
i. Biocompatibility Test
ii. Pre- Clinical Physical Test
iii. Pre- Clinical Animal Studies
18
Pre-clinical Test
Biocompatibility Test
➢ For medical devices that directly or indirectly contact patients, biocompatibility testing is
required to obtain regulatory approval in most markets. Biocompatibility tests help determine
whether a device performs as intended without causing any adverse or harmful effects for
patients or users, and mitigate any biological risks posed by the device.
➢ ISO 10993 – Biological Evaluation of medical device
➢ Primary test category a shown below:
22
4.4 Clinical Evidence
This section should indicate how any applicable requirements of the Essential Principles for clinical
evaluation of the device have been met. Where applicable, this evaluation may take the form of
(a) a systematic review of existing bibliography,
‘A review of a clearly formulated question that uses systematic and explicit methods to identify,
select, and critically appraise relevant research, and to collect and analyse data from the studies
that are included in the review. Statistical methods (meta-analysis) may or may not be used to
analyse and summarise the results of the included studies’ (Cochrane Collaboration, 2014)
(b) clinical experience with the same or similar devices, or
-Demonstrate the equivalence. Similar means that no clinically significant difference in the
performance and safety of the device would be due to differences;
(c) clinical investigation (ISO 14155 )
- Most likely to be needed for higher risk class devices or for devices where there is little or no
clinical experience
23
4.5. Use of Existing Bibliography
• Contain copies of all the literature studies, or existing bibliography
• Relevant publications in peer-reviewed scientific literature
24
5. Medical Device Labelling
.
Medical Device Labeling
(Sixth Schedule of Medical Device Regulations 2012)
Do provide:
5.1. Declaration on Labeling
5.2. Sample of Device Labeling
5.3. Document on IFU, User Manual, Technical Manual, Brochure, etc
26
6. Risk Management
.
Risk Management
➢ Risk management is a key component in demonstrating regulatory
compliance for medical devices.
➢ Recommended to follow ISO 14971.
➢ This standard will help manufacturers to establish a medical
device risk management process that can be used to identify hazard, to
estimate and evaluate risks, and to implement and monitor the
effectiveness of risk control measures during the product life cycle.
28
Overview Of Risk Management Process
Establish framework and
specify intended used.
Identify hazards
30
6.3 Risk Controls
• to reduce and mitigate unacceptable risks
• Priorities; 1) Product Design
2) Protective measures incorporated with in the medical device
3) Labeling, instructions for use
6.4 Residual Risk Acceptability
• to evaluate and document whether or not the product meets the
acceptability criteria defined by the company.
6.5 Production & Post production Information
• involve systematic review of risk management file and be
updated when events such as complaints, product feedback, non-
conformances, etc. occur.
31
7. Manufacturer Information
.
7.1. Manufacture information
• Provide address of all manufacturers involved in the device
manufacturing process
33
Thank You